Radioprotective effects of troxerutin against gamma irradiation in mice liver

References

• Auteri A, Blardi P, Frigerio C, de Lillo L, di Perri T. 1990. Pharmacodynamics of troxerutine in patients with chronic venous insufficiency: Correlations with plasma drug levels. International Journal of Clinical Pharmacology Research 10:235–241.
   PubMedGoogle Scholar
• Biosseau M, Freyburger G, Beylot C, Busquet M. 1986. Erythrocyte aggregation and parameters hemorheologic at the insufficiency venous influence of the troxerutin. Arteries and Veins 5:231–234.
   Google Scholar
• Blasig IE, Loewe H, Elbert B. 1987. Radical trapping and lipid peroxidation during myocardial reperfusion injury – radical scavenging by troxerutin in comprision to mannitol. Biomedica Biochimica Acta 47:S539–544.
   Google Scholar
• Blasig IE, Loewe H, Elbert B. 1988. Effect of troxerutin and methionine on spin trapping of free oxy-radicals. Biomedica Biochimica Acta 47:S252–255.
   Google Scholar
• Boisseu MR, Taccoen A, Garreau C, Vergnes C, Roudaut MF, Garreau-Gomez B. 1995. Fibrinolysis and hemorheology in chronic venous insufficiency: A double blind study of troxerutin efficiency. Journal of Cardiovascular Surgery (Torino) 36:369–374.
   PubMed Web of Science ®Google Scholar
• Dumont FJ, Le Roux A, Bischoff P. 2010. Radiation countermeasure agents: An update. Expert Opinion on Therapeutic Patents 20:73–101
   PubMed Web of Science ®Google Scholar
• Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. 1994. A randomized, double masked study on the treatment of retinal vein occlusion with troxerutin. American Journal of Ophthalmology 118:421–429.
   PubMed Web of Science ®Google Scholar
• Gracy RW, Talent JM, Kong Y, Conard CC. 1999. Reactive oxygen species: The unavoidable environmental insults? Mutation Research 428:17–22.
   PubMed Web of Science ®Google Scholar
• Grötz KA, Henneicke-von Zepelin HH, Kohnen R, al-Nawas B, Bockisch A, Kutzner J, Wüstenberg P, Naser-Hijazi B, Belz GG, Wagner W. 1999. Prospective double-blind study of radioxerostomia with coumarin/troxerutine in patients with head and neck cancer. Strahlentherapie and Onkologie 175:397–404.
   PubMed Web of Science ®Google Scholar
• Gueguen-Duchesne M, Durand F, Le Goff MC, Genetet B. 1988. Effects of troxerutin on the hemorhhological parameters of patients with moderate arterial hypertension. Progress in Clinical and Biological Research 280:401–406.
   PubMedGoogle Scholar
• Halliwell B, Gutteridge JMC. 2000. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press.
   Google Scholar
• Hosseinimehr SJ. 2007. Foundation review: Trends in the development of radioprotective agents. Drug Discovery Today 12:794–805.
   PubMed Web of Science ®Google Scholar
• Incandela L, De Sanctis MT, Cesarone MR, Laurora G, Belcaro G, Taccoen A. 1996. Efficacy of troxerutin in patients with chronic venous insufficiency: A double-blind, placebo-controlled study. Advances in Therapy 13:161–166.
   Web of Science ®Google Scholar
• Kessler M, Ubeaud G, Walter T, Sturm F, Jung L. 2002. Free radical scavenging and skin penetration on troxerutin and vitamin derivatives. Journal of Dermatological Treatment 13:133–141.
   PubMed Web of Science ®Google Scholar
• Krupinski K, Giedrojc J, Bielawiec M. 1996. Effect of troxerutin on laser-induced thrombus formation in rat mesenteric vessels, coagulation parameter and platelet function. Polish Journal of Pharmacology 48:335–339.
   PubMedGoogle Scholar
• Maunch P, Constine L, Greenberger J, Knospe W, Sullival J, Deeg HJ. 1995. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology Biology Physics 31:1319–1339.
   PubMed Web of Science ®Google Scholar
• Maurya DK, Balakrishnan S, Salvi VP, Nair CK. 2005. Protection of cellular DNA from gamma-radiation-induced damages and enhancement in DNA repair by troxerutin. Molecular and cellular biochemistry 280:57–68.
   PubMed Web of Science ®Google Scholar
• Maurya DK, Salvi VP, Nair CK. 2004. Radioprotection of normal tissues in tumour-bearing mice by troxerutin. Journal of Radiation Research 45:221–228.
   PubMed Web of Science ®Google Scholar
• Nair CKK, Parida DK, Nomura T. 2001. Radio-protectors in radiotherapy. Journal of Radiation Research 42:21–37.
   PubMed Web of Science ®Google Scholar
• Rehn D, Golden G, Nocker W, Diebschlag W, Lehmacher W. 1993. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency. Arzneimittel-forschung-drug Research 43:1060–1063.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Biswas N, Kapoor S, Mahal HS, Nair CKK, Mukherjee T. 2005. One-electron redox reactions of troxerutin in aqueous solutions. Research on Chemical Intermediates 31:857–866.
   Web of Science ®Google Scholar
• Schuller-Petrovic S, Wolzt M, Bohler K, Jilma B, Eichler HG. 1994. Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins. Clinical Pharmacology & Therapeutics 56:452–459.
   PubMed Web of Science ®Google Scholar
• Umadevi P. 1998. Normal tissue protection in cancer therapy: Progress and prospects. Acta Oncologica 37:247–251.
   PubMed Web of Science ®Google Scholar
• Vanscheidt W, Rabe E, Naser-Hijazi B, Ramelet AA, Partsch H, Diehm C. 2002. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: A double blind placebo-controlled randomized study. Vasa-Journal of Vascular Diseases 31:185–190.
   PubMed Web of Science ®Google Scholar
• Vin F, Chabanel A, Taccoen A, Ducros J, Gruffaz J, Hutinel B. 1992. Action of the troxerutin on clinical parameters, plethysmographics and rheologics of venous insufficiency of the lower limbs: A placebo-controlled trial. Arteries and Veins 11:333–342.
   Google Scholar
• Vin F, Chabanel A, Taccoen A, Ducros J, Gruffaz J, Hutinel B. 1994. Double blind trial of the efficacy of troxerutin in chronic venous insufficiency. Phlebologie 9:71–78.
   Google Scholar
• Wadworth A, Faulds D. 1992. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs 44:1013–1032.
   PubMed Web of Science ®Google Scholar
• Weiss JF. 1997. Pharmacological approaches to protection against radiation-induced lethality and other damages. Environmental Health Perspectives 105:1473–1478.
   PubMed Web of Science ®Google Scholar
• Weiss JF, Landauer MR. 2009. History and development of radiation-protective agents. International Journal of Radiation Biology 85: 539–573.
   PubMed Web of Science ®Google Scholar
• Wenisch C. 2001. Effect of bioflavonoids (trihydroxyethylrutin and disodium flavodate) in vitro on neutrophil reactive oxygen production and phagocytotic ability to assessed by flow cytometry. Current Medical Research and Opinion 17:123–127.
   PubMed Web of Science ®Google Scholar